AC Immune ACIU
NASDAQ ACIU
$2.86 -0.07 (-2.39%)
At close: Sep 4, 2026 · 4:00 PM EDT

AC Immune (ACIU) Goodwill & Intangibles (2021 - 2026)

AC Immune (ACIU) posted quarterly Goodwill & Intangibles of $64.4 billion for Q1 2026, up 114712.68% year-over-year from N/an in Q1 2025, and up 2.06% quarter-over-quarter from $63.1 billion in Q4 2025.

Analysis

AC Immune (ACIU) Goodwill & Intangibles (2021 - 2026) Analysis & Trends

AC Immune (ACIU) has reported Goodwill & Intangibles for 6 consecutive years, with $64.4 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles rose 114712.68% year-over-year to $64.4 billion; the TTM figure through Mar 2026 stood at $64.4 billion (up 114712.68% YoY), while the FY2025 annual figure was $60.8 billion, up 105559.69% from the prior year.
  • Goodwill & Intangibles improved to $64.4 billion in Q1 2026 per ACIU's latest filing, from $63.1 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $64.4 billion in Q1 2026 and bottomed at $52.2 million in Q3 2022.
  • Historically, Goodwill & Intangibles has averaged $17.2 billion across 5 years, with a median of $57.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Goodwill & Intangibles slumped 99.9% — and 2026, when it surged 114712.68%.
  • AC Immune's Goodwill & Intangibles stood at $52.3 million in 2022, then surged by 108506.04% to $56.8 billion in 2023, then plunged by 99.9% to $57.6 million in 2024, then jumped by 109505.42% to $63.1 billion in 2025, then rose by 2.06% to $64.4 billion in 2026.
  • Business Quant data shows ACIU's Goodwill & Intangibles at $64.4 billion in Q1 2026, $63.1 billion in Q4 2025, and $63.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 AC Immune 285.13 Mn 285.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.79 Mn
Mar 31, 2026 64.38 Mn
Dec 31, 2025 63.08 Mn
Sep 30, 2025 63.03 Mn
Jun 30, 2025 60.90 Mn
Mar 31, 2025 56.08 Mn
Dec 31, 2024 57.55 Mn
Sep 30, 2024 58.19 Mn
Jun 30, 2024 55.75 Mn
Mar 31, 2024 57.76 Mn
Dec 31, 2023 56.84 Mn
Sep 30, 2023 57.08 Mn
Jun 30, 2023 56.07 Mn
Mar 31, 2023 54.51 Mn
Dec 31, 2022 52.33 Mn
Sep 30, 2022 52.20 Mn
Jun 30, 2022 52.35 Mn
Mar 31, 2022 54.59 Mn
Dec 31, 2021 54.68 Mn